APA (7th ed.) Citation

X, D., W, Y., X, L., & M, W. (2026). In Vivo T-Cell Engineering: Revolution in Delivery Strategies and Clinical Translation. BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy, 40(3), 433. https://doi.org/10.1007/s40259-026-00771-3

Chicago Style (17th ed.) Citation

X, Dong, Yan W, Long X, and Wu M. "In Vivo T-Cell Engineering: Revolution in Delivery Strategies and Clinical Translation." BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy 40, no. 3 (2026): 433. https://doi.org/10.1007/s40259-026-00771-3.

MLA (9th ed.) Citation

X, Dong, et al. "In Vivo T-Cell Engineering: Revolution in Delivery Strategies and Clinical Translation." BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy, vol. 40, no. 3, 2026, p. 433, https://doi.org/10.1007/s40259-026-00771-3.